Heart failure and hepatitis in a patient taking tocainide.
We report, for the first time to our knowledge, heart failure and liver abnormalities which developed after 2 months of treatment with tocainide.
D000638:Amiodarone / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D008012:Lidocaine / Q000009:adverse effects / Q000031:analogs & derivatives*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D016677:Tocainide
D016677:Tocainide; D008012:Lidocaine; D000638:Amiodarone